152 related articles for article (PubMed ID: 15868911)
1. Pre-clinical evaluation of the activity of irinotecan as a basis for regional chemotherapy.
Hofmann C; Buttenschoen K; Straeter J; Henne-Bruns D; Kornmann M
Anticancer Res; 2005; 25(2A):795-804. PubMed ID: 15868911
[TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin exerts potent in vitro cytotoxicity in colorectal and pancreatic cancer cell lines and liver metastases.
Kornmann M; Fakler H; Butzer U; Beger HG; Link KH
Anticancer Res; 2000; 20(5A):3259-64. PubMed ID: 11062751
[TBL] [Abstract][Full Text] [Related]
3. Pre-clinical evaluation of the activity of gemcitabine as a basis for regional chemotherapy of pancreatic and colorectal cancer.
Kornmann M; Butzer U; Blatter J; Beger HG; Link KH
Eur J Surg Oncol; 2000 Sep; 26(6):583-7. PubMed ID: 11034810
[TBL] [Abstract][Full Text] [Related]
4. [Combination chemotherapy with hepatic arterial infusion of 5-fluorouracil (5-FU) and systemic irinotecan (CPT-11) in patients with unresectable liver metastases from colorectal cancer].
Shitara K; Munakata M; Kudo T; Kasai M; Muto O; Okada R; Mitobe S; Ishiguro A; Sakuraba H; Ikami I; Sakata Y
Gan To Kagaku Ryoho; 2006 Dec; 33(13):2033-7. PubMed ID: 17197748
[TBL] [Abstract][Full Text] [Related]
5. Weekly hepatic arterial infusion of 5-fluorouracil and subsequent systemic chemotherapy for liver metastases from colorectal cancer.
Hosokawa A; Yamada Y; Shimada Y; Muro K; Matsumura Y; Fujita S; Akasu T; Moriya Y; Shirao K
Jpn J Clin Oncol; 2003 Mar; 33(3):132-5. PubMed ID: 12672790
[TBL] [Abstract][Full Text] [Related]
6. Hepatic metastases of colorectal cancer: locoregional intra-arterial treatment.
Pasetto LM; Merenda R; Pilati P; Sinigaglia G; Monfardini S
Anticancer Res; 2006; 26(6C):4785-92. PubMed ID: 17214342
[TBL] [Abstract][Full Text] [Related]
7. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
[TBL] [Abstract][Full Text] [Related]
8. Combined systemic chronotherapy and hepatic artery infusion for the treatment of metastatic colorectal cancer confined to the liver.
Shimonov M; Hayat H; Chaitchik S; Brener J; Schachter P; Czerniak A
Chemotherapy; 2005 May; 51(2-3):111-5. PubMed ID: 15886466
[TBL] [Abstract][Full Text] [Related]
9. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
Kemeny N; Jarnagin W; Paty P; Gönen M; Schwartz L; Morse M; Leonard G; D'Angelica M; DeMatteo R; Blumgart L; Fong Y
J Clin Oncol; 2005 Aug; 23(22):4888-96. PubMed ID: 16009951
[TBL] [Abstract][Full Text] [Related]
11. [Prehepatectomy chemotherapy using hepatic artery infusion plus systemic chemotherapy for liver metastases from colorectal cancer].
Tanaka K; Kumamoto T; Nojiri K; Mori R; Matsuyama R; Takeda K; Ota M; Akiyama H; Ichikawa Y; Endo I
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2267-70. PubMed ID: 21224543
[TBL] [Abstract][Full Text] [Related]
12. Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer.
Kemeny N; Jarnagin W; Gonen M; Stockman J; Blumgart L; Sperber D; Hummer A; Fong Y
J Clin Oncol; 2003 Sep; 21(17):3303-9. PubMed ID: 12947066
[TBL] [Abstract][Full Text] [Related]
13. Regional administration of irinotecan in combination with 5-fluorouracil and leucovorin in patients with colorectal cancer liver metastases--a pilot experience.
Melichar B; Dvorák J; Jandík P; Tousková M; Malírová E; Megancová J; Voboril Z
Hepatogastroenterology; 2001; 48(42):1721-6. PubMed ID: 11813608
[TBL] [Abstract][Full Text] [Related]
14. Therapy for advanced colorectal cancer.
Benson AB
Semin Oncol; 1998 Oct; 25(5 Suppl 11):2-11. PubMed ID: 9786311
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy for liver metastasis of colorectal cancer].
Amano M; Niinobu T; Itani Y; Nishikawa Y; Nakagawa S; Higaki N; Hayashida H; Fujita M; Sakon M
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1721-3. PubMed ID: 16315920
[TBL] [Abstract][Full Text] [Related]
16. Hepatic arterial infusion with oxaliplatin, irinotecan and doxifluridine for unresectable liver metastases of colorectal cancer.
Chen Y; Yan Z; Wang J; Wang X; Luo J; Liu Q
Anticancer Res; 2010 Jul; 30(7):3045-9. PubMed ID: 20683053
[TBL] [Abstract][Full Text] [Related]
17. Repeated hepatic intra-arterial chemotherapy based on results of anticancer drug sensitivity test in patients with synchronous hepatic metastases from colorectal cancer.
Matsuoka H; Nagaya M; Tsukikawa S; Yanagi Y; Isogai A; Kubota S
Surgery; 2006 Sep; 140(3):387-95. PubMed ID: 16934600
[TBL] [Abstract][Full Text] [Related]
18. Is repeated treatment with a 5-fluorouracil-based regimen useful in colorectal cancer?
Goldberg RM
Semin Oncol; 1998 Oct; 25(5 Suppl 11):21-8. PubMed ID: 9786313
[TBL] [Abstract][Full Text] [Related]
19. Cetuximab with hepatic arterial infusion of chemotherapy for the treatment of colorectal cancer liver metastases.
Neyns B; Aerts M; Van Nieuwenhove Y; Fontaine C; De Coster L; Schallier D; Vanderauwera J; De Munck F; Vandenbroucke F; Everaert H; Meert V; De Mey J; De Ridder M; Delvaux G; De Grève J
Anticancer Res; 2008; 28(4C):2459-67. PubMed ID: 18751435
[TBL] [Abstract][Full Text] [Related]
20. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
Ducreux M; Ychou M; Laplanche A; Gamelin E; Lasser P; Husseini F; Quenet F; Viret F; Jacob JH; Boige V; Elias D; Delperro JR; Luboinski M;
J Clin Oncol; 2005 Aug; 23(22):4881-7. PubMed ID: 16009952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
